Sepsis Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Sepsis Diagnostics Market
The sepsis diagnostics market size was valued at USD 840.5 billion in 2023, and the market is now projected to grow from USD 918 billion in 2024 to USD 1953.6 billion by 2032, exhibiting a CAGR of 9.9% during the forecast period of 2024-2032.
In 2020, the COVID-19 pandemic had a minor high-quality have an effect on available on the market for sepsis diagnostics due to better occurrence amongst COVID-19-wonderful patients. In 2021, affected man or woman visits and organization sales recovered to pre-pandemic ranges, indicating that the market will preserve to increase step by step from 2024-2032.
The developing occurrence of this illness has a sizable economic and healthcare impact, mainly in developing nations. Various authorities and non-governmental groups are trying to elevate public awareness approximately this condition. These initiatives include screening, coaching, measuring sepsis package deal performance, the use of current diagnostics to enhance patient results, and enforcing remedy protocols. Springer Nature Switzerland AG's October 2021 paper found that developing programs and recommendations improves adherence to bundles and decreases mortality in patients with these illnesses.
Key firms in the worldwide market are increasingly focusing on developing fast diagnostic or point-of-care procedures. Rapid diagnostic approaches for sepsis have increased speed, consistency, and effectiveness. Compared to manual procedures, these strategies provide faster and more consistent outcomes. These strategies have the advantage of using less healthcare personnel and addressing the scarcity of competent specialists in diagnostic services. Leading competitors are focusing on developing quick diagnostic and point-of-care approaches, which are projected to drive sepsis diagnostics market growth.
Comprehensive Analysis of Sepsis Diagnostics Market
The global sepsis diagnostics market is divided into reagents & consumables, instruments, microbiology, molecular diagnostics, immunoassays, and others. The reagents & consumables segment is expected to grow due to their widespread use in diagnostic procedures. The instruments segment is expected to see growth due to technological advancements and improvements in healthcare infrastructure. The immunoassays segment is projected to account for the second-largest market position due to R&D initiatives. The market is segmented into conventional and automated methods, with the automated segment holding the largest share due to its high efficacy and specificity. The laboratory tests segment is expected to expand due to increasing hospitalizations and improvements in healthcare facilities. The fungal segment is expected to grow at a substantial CAGR due to its potential for people with weak immune systems. The end user segment is divided into diagnostic centers, hospitals & clinics, and others.
The North America region lead the sepsis diagnostics market share by benefitting a market size of USD 392.8 billion in 2023 due to the region is expected to lead the worldwide market during the forecast period. The region's market dominance stems from high demand for these medicines, driven by the prevalence of the condition, quick adoption of modern diagnostics, and advantageous reimbursement policies.
The worldwide market is fragmented and dominated by a few major companies. BioMérieux SA, Thermo Fisher Scientific Inc., Danaher, and BD (Becton, Dickinson, and Company) are leading market players with diverse diagnostic portfolios and established geographical presence. BioMérieux SA has successfully captured a significant market share with improved medication introductions for this condition. Danaher's subsidiary, Beckman Coulter, is likewise a market leader.
In November 2023, the University of Oxford collaborated with Danaher Corporation to create a test for sepsis that allows for more precise medical therapy.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 9.9% from 2024-2032
Unit Value (USD million)
Segmentation By Product Type
Instruments
Reagents & Consumables
By Technology
Microbiology
Molecular Diagnostics
Immunoassays
Others
By Method
Conventional
Automated
By Test Type
Laboratory Tests
Point-of-Care Tests
By Pathogen
Bacterial
Fungal
Others
By End User
Hospitals & Clinics
Diagnostic Centers
Others
By Region
North America (By Product Type, Technology, Method, Test Type, Pathogen, End User, and Country)
- U.S. (By Product Type)
- Canada (By Product Type)
Europe (By Product Type, Technology, Method, Test Type, Pathogen, End User, and Country/Sub-Region)
- Germany (By Product Type)
- U.K. (By Product Type)
- France (By Product Type)
- Italy (By Product Type)
- Spain (By Product Type)
- Rest of Europe (By Product Type)
Asia Pacific (By Product Type, Technology, Method, Test Type, Pathogen, End User, and Country/Sub-Region)
- China (By Product Type)
- India (By Product Type)
- Japan (By Product Type)
- Australia (By Product Type)
- Rest of Asia Pacific (By Product Type)
Rest of the World (By Product Type, Technology, Method, Test Type, Pathogen, and End User)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.